MENU
+Compare
AUTL
Stock ticker: NASDAQ
AS OF
Jun 23, 04:59 PM (EDT)
Price
$2.21
Change
+$0.15 (+7.28%)
Capitalization
588.16M

AUTL Autolus Therapeutics plc Forecast, Technical & Fundamental Analysis

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AUTL with price predictions
Jun 23, 2025

AUTL in upward trend: 10-day moving average broke above 50-day moving average on May 28, 2025

The 10-day moving average for AUTL crossed bullishly above the 50-day moving average on May 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

AUTL moved above its 50-day moving average on May 20, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AUTL advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 139 cases where AUTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AUTL moved out of overbought territory on June 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AUTL as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AUTL turned negative on June 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AUTL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AUTL broke above its upper Bollinger Band on June 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.585) is normal, around the industry mean (16.460). P/E Ratio (0.000) is within average values for comparable stocks, (58.911). AUTL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.291). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (65.359) is also within normal values, averaging (252.526).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AUTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AUTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AUTL is expected to report earnings to fall 11.81% to -22 cents per share on July 31

Autolus Therapeutics plc AUTL Stock Earnings Reports
Q2'25
Est.
$-0.23
Q1'25
Est.
$-0.26
Q4'24
Beat
by $0.12
Q3'24
Missed
by $0.10
Q2'24
Missed
by $0.03
The last earnings report on May 08 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 2.23M shares outstanding, the current market capitalization sits at 588.16M.
A.I. Advisor
published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRVRX8.260.11
+1.35%
NYLI CBRE Real Estate Fund Investor Cl
JETIX15.80N/A
N/A
abrdn Focused Em Markets ex-China Instl
PCIEX18.79N/A
N/A
PACE International Equity P
VTMFX45.55N/A
N/A
Vanguard Tax-Managed Balanced Adm
MNDBX14.88N/A
N/A
MFS New Discovery B

AUTL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with CRSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
+7.80%
CRSP - AUTL
47%
Loosely correlated
+2.94%
ERAS - AUTL
45%
Loosely correlated
-0.71%
OCUL - AUTL
44%
Loosely correlated
+2.83%
IMCR - AUTL
44%
Loosely correlated
-0.70%
ABEO - AUTL
42%
Loosely correlated
-1.36%
More